Abstract:Key PointsSecreted membrane vesicles are heterogeneous spherical structures that are limited by a lipid bilayer and contain cytoplasmic components from the donor cell. Secreted vesicles can be classified according to their intracellular origin: microvesicles, ectosomes and viruses are shed from the plasma membrane, whereas exosomes and exosome-like vesicles form in intracellular multivesicular compartments and are secreted following fusion of these compartments with the plasma membrane.Membrane vesicles can be captured by neighbouring recipient cells through the interaction of vesicular ligands with cellular receptors (such as interactions between intracellular adhesion molecule 1 and lymphocyte function-associated antigen 1, phosphatidylserine and T cell immunoglobulin domain and mucin domain protein 4, as well as integrins and adhesion molecules). The precise mechanisms of interaction remain poorly characterized, but several studies suggest that vesicles can be internalized and might fuse with the recipient cell either at the plasma membrane or after internalization.Exosomes and microvesicles contain transmembrane proteins, soluble cytoplasmic components and lipids, but also mRNAs and microRNAs derived from the donor cell. Recent in vitro studies show that mRNAs can be transferred to and transcribed in recipient cells, suggesting that secreted vesicles could modify the genetic profile of recipient cells.Exosomes secreted by dendritic cells (DCs) bear functional preformed peptide–MHC complexes and can either directly activate antigen-specific effector T cells or transfer these complexes to recipient DCs to activate naive antigen-specific T cells. Material transferred by exosomes derived from all cell types (in particular tumours) can be processed and presented by recipient DCs.Exosomes and microvesicles secreted by tumours have been shown to inhibit immune responses in an antigen-independent manner, especially by switching monocyte and T cell differentiation towards a tolerogenic phenotype. However, when injected with adjuvants or purified from stressed tumour cells, exosomes can induce potent antitumour responses.Most studies described in this Review were carried out using vesicles purified in vitro from cultured cells or ex vivo from biological fluids. Membrane vesicles are secreted in vivo, but the demonstration of a function for this in vivo secretion will require the identification of tools to specifically inhibit their secretion.Exosomes derived from DCs or tumours from patients with cancer have been used for immunotherapies, but clinical responses are limited. Future clinical trials will benefit from recent preclinical studies on exosomes and should involve a combination of exosomes and other immunomodulatory approaches.

Endolysosomal vesicles at the center of B cell activation

Role of canonical and noncanonical autophagy pathways in shaping the life journey of B cells

The B cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors

Caveolin-1, tetraspanin CD81 and flotillins in lymphocyte cell membrane organization, signaling and immunopathology

B Cell Activation and Autoantibody Production in Autoimmune Diseases.

How B cells capture, process and present antigens: a crucial role for cell polarity

Exosome: from internal vesicle of the multivesicular body to intercellular signaling device

Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular

Cytosol to lysosome transport of intracellular antigens during immune surveillance

B cells secrete functional antigen-specific IgG antibodies on extracellular vesicles

Lysosome remodelling and adaptation during phagocyte activation

CD36 and LC3B initiated autophagy in B cells regulates the humoral immune response

SNX5 promotes antigen presentation in B cells by dual regulation of actin and lysosomal dynamics

Lipid Metabolism in regulation of B cell development and autoimmunity

Extracellular vesicles and microvilli in the immune synapse

Lysosomal exocytosis: From cell protection to protumoral functions

B cells in autoimmune and neurodegenerative central nervous system diseases

Membrane vesicles as conveyors of immune responses

Both sides now: evolutionary traits of antigens and B cells in tolerance and activation

B cell depletion therapy in autoimmune diseases.

Antigen presentation by B cells enables epitope spreading across an MHC barrier